...
首页> 外文期刊>American Journal of Immunology >Expression of Toll-like Receptors (TLRs) and Nucleotide-binding Oligomerization Domain (NODs) in murine peritoneal macrophages on in vitro treatment with Thymosin α 1 | Science Publications
【24h】

Expression of Toll-like Receptors (TLRs) and Nucleotide-binding Oligomerization Domain (NODs) in murine peritoneal macrophages on in vitro treatment with Thymosin α 1 | Science Publications

机译:胸腺素α1体外治疗小鼠腹膜巨噬细胞中Toll样受体(TLR)和核苷酸结合寡聚域(NOD)的表达科学出版物

获取原文
           

摘要

> Thymosin ? 1 (T?1) treatment of murine peritoneal macrophages in vitro induces the expression of TLRs and Nod2 proteins. Enhanced expressions of TLR2, -4, -5, -6, -7, -8, -9 and Nod2 were observed by RT-PCR and western blotting. Expression of downstream signaling molecules - MyD88, IRAK1, TRAF6, IRF3 were also up regulated on treatment with Tα1. It was also observed that pretreatment of macrophages with pharmacological inhibitors strongly down regulated the Tα1 induced expression of TLR2,-4,-9. Macrophages pretreated with Tα1 and then incubated with ligands for TLRs - Zymosan A, LPS and CpG DNA, showed significantly enhanced production of proinflammatory cytokines, than the macrophages treated with ligands alone. This suggests that pretreatment of macrophages with Tα1 makes them functionally more responsive to further challenge with TLR ligands.
机译: >胸腺素? 1(T?1)体外处理鼠腹膜巨噬细胞可诱导TLRs和Nod2蛋白的表达。通过RT-PCR和蛋白质印迹观察到TLR2,-4,-5,-6,-7,-8,-9和Nod2的表达增强。下游信号分子-MyD88,IRAK1,TRAF6,IRF3的表达在用Tα1处理时也被上调。还观察到用药理学抑制剂预处理巨噬细胞强烈下调了Tα1诱导的TLR2,-4,-9的表达。与仅用配体处理的巨噬细胞相比,用Tα1预处理的巨噬细胞然后与TLR-配体Zymosan A,LPS和CpG DNA的配体一起温育,显示出促炎细胞因子的产生显着增强。这表明用Tα1预处理巨噬细胞使它们在功能上对TLR配体的进一步攻击更具反应性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号